Literature DB >> 27345267

Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration.

Saurabh Kumar Jha1, Niraj Kumar Jha1, Dhiraj Kumar1, Rashmi K Ambasta1, Pravir Kumar2.   

Abstract

Mounting evidence suggests a link between metabolic syndrome (MetS) such as diabetes, obesity, non-alcoholic fatty liver disease in the progression of Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative diseases (NDDs). For instance, accumulated Aβ oligomer is enhancing neuronal Ca2+ release and neural NO where increased NO level in the brain through post translational modification is modulating the level of insulin production. It has been further confirmed that irrespective of origin; brain insulin resistance triggers a cascade of the neurodegeneration phenomenon which can be aggravated by free reactive oxygen species burden, ER stress, metabolic dysfunction, neuorinflammation, reduced cell survival and altered lipid metabolism. Moreover, several studies confirmed that MetS and diabetic sharing common mechanisms in the progression of AD and NDDs where mitochondrial dynamics playing a critical role. Any mutation in mitochondrial DNA, exposure of environmental toxin, high-calorie intake, homeostasis imbalance, glucolipotoxicity is causative factors for mitochondrial dysfunction. These cumulative pleiotropic burdens in mitochondria leads to insulin resistance, increased ROS production; enhanced stress-related enzymes that is directly linked MetS and diabetes in neurodegeneration. Since, the linkup mechanism between mitochondrial dysfunction and disease phenomenon of both MetS and NDDs is quite intriguing, therefore, it is pertinent for the researchers to identify and implement the therapeutic interventions for targeting MetS and NDDs. Herein, we elucidated the pertinent role of MetS induced mitochondrial dysfunction in neurons and their consequences in NDDs. Further, therapeutic potential of well-known biomolecules and chaperones to target altered mitochondria has been comprehensively documented. This article is part of a Special Issue entitled: Oxidative Stress and Mitochondrial Quality in Diabetes/Obesity and Critical Illness Spectrum of Diseases - edited by P. Hemachandra Reddy.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomolecules; Chaperones; Metabolic syndrome (MetS); Mitochondrial dysfunction; Neurodegenerative disorders (NDDs); Therapeutics

Mesh:

Substances:

Year:  2016        PMID: 27345267     DOI: 10.1016/j.bbadis.2016.06.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  26 in total

Review 1.  The Drosophila melanogaster as Genetic Model System to Dissect the Mechanisms of Disease that Lead to Neurodegeneration in Adrenoleukodystrophy.

Authors:  Margret H Bülow; Brendon D Parsons; Francesca Di Cara
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 2.  A review of Mendelian randomization in amyotrophic lateral sclerosis.

Authors:  Thomas H Julian; Sarah Boddy; Mahjabin Islam; Julian Kurz; Katherine J Whittaker; Tobias Moll; Calum Harvey; Sai Zhang; Michael P Snyder; Christopher McDermott; Johnathan Cooper-Knock; Pamela J Shaw
Journal:  Brain       Date:  2022-04-29       Impact factor: 15.255

3.  Enhancing the potential of aged human articular chondrocytes for high-quality cartilage regeneration.

Authors:  He Shen; Yuchen He; Ning Wang; Madalyn R Fritch; Xinyu Li; Hang Lin; Rocky S Tuan
Journal:  FASEB J       Date:  2021-03       Impact factor: 5.191

Review 4.  Alterations in the E3 ligases Parkin and CHIP result in unique metabolic signaling defects and mitochondrial quality control issues.

Authors:  Britney N Lizama; Amy M Palubinsky; BethAnn McLaughlin
Journal:  Neurochem Int       Date:  2017-08-26       Impact factor: 3.921

5.  Comprehensive Multi-omics Analysis Reveals Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact.

Authors:  Willian A da Silveira; Hossein Fazelinia; Sara Brin Rosenthal; Evagelia C Laiakis; Man S Kim; Cem Meydan; Yared Kidane; Komal S Rathi; Scott M Smith; Benjamin Stear; Yue Ying; Yuanchao Zhang; Jonathan Foox; Susana Zanello; Brian Crucian; Dong Wang; Adrienne Nugent; Helio A Costa; Sara R Zwart; Sonja Schrepfer; R A Leo Elworth; Nicolae Sapoval; Todd Treangen; Matthew MacKay; Nandan S Gokhale; Stacy M Horner; Larry N Singh; Douglas C Wallace; Jeffrey S Willey; Jonathan C Schisler; Robert Meller; J Tyson McDonald; Kathleen M Fisch; Gary Hardiman; Deanne Taylor; Christopher E Mason; Sylvain V Costes; Afshin Beheshti
Journal:  Cell       Date:  2020-11-25       Impact factor: 41.582

6.  Metabolic network failures in Alzheimer's disease: A biochemical road map.

Authors:  Jon B Toledo; Matthias Arnold; Gabi Kastenmüller; Rui Chang; Rebecca A Baillie; Xianlin Han; Madhav Thambisetty; Jessica D Tenenbaum; Karsten Suhre; J Will Thompson; Lisa St John-Williams; Siamak MahmoudianDehkordi; Daniel M Rotroff; John R Jack; Alison Motsinger-Reif; Shannon L Risacher; Colette Blach; Joseph E Lucas; Tyler Massaro; Gregory Louie; Hongjie Zhu; Guido Dallmann; Kristaps Klavins; Therese Koal; Sungeun Kim; Kwangsik Nho; Li Shen; Ramon Casanova; Sudhir Varma; Cristina Legido-Quigley; M Arthur Moseley; Kuixi Zhu; Marc Y R Henrion; Sven J van der Lee; Amy C Harms; Ayse Demirkan; Thomas Hankemeier; Cornelia M van Duijn; John Q Trojanowski; Leslie M Shaw; Andrew J Saykin; Michael W Weiner; P Murali Doraiswamy; Rima Kaddurah-Daouk
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 16.655

Review 7.  The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease.

Authors:  Johanna O Ojala; Elina M Sutinen
Journal:  J Clin Med       Date:  2017-05-21       Impact factor: 4.241

Review 8.  Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer's Disease.

Authors:  Chanchal Sharma; Sehwan Kim; Youngpyo Nam; Un Ju Jung; Sang Ryong Kim
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

Review 9.  Systems modeling of metabolic dysregulation in neurodegenerative diseases.

Authors:  Priyanka Baloni; Cory C Funk; Ben Readhead; Nathan D Price
Journal:  Curr Opin Pharmacol       Date:  2021-08-02       Impact factor: 4.768

10.  Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's disease.

Authors:  Avner Thaler; Shani Shenhar-Tsarfaty; Yanay Shaked; Tanya Gurevich; Nurit Omer; Anat Bar-Shira; Mali Gana-Weisz; Orly Goldstein; Meir Kestenbaum; Jesse M Cedarbaum; Avi Orr-Urtreger; Nir Giladi; Anat Mirelman
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.